Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Summit Therapeutics Inc. Common Stock](/topic/$smmt)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% +16%  
**6 Months**: XX% +5%  
**1 Year**: XX% +14%  
**1-Year High**: XXX% on 2025-10-06  
**1-Year Low**: XX% on 2025-03-23  

**Most Supportive Themes**
- **Upcoming Phase X Data:** (40%) The anticipation of upcoming Phase X data fuels investor excitement.
- **Bullish Sentiment and Recognition:** (30%) Positive mentions and recognition of Summit Therapeutics as a potential long-term holding boost investor confidence.
- **Strategic Partnerships:** (10%) Strategic collaborations, such as the ADC combo deal with Pfizer, are viewed positively by investors.
  
**Most Critical Themes**
- **Competition Intensification:** (3%)  Investors are concerned about increased competition in the PD-1/VEGF bispecific antibody market.
- **Conflicting Macroeconomic Signals:** (2%)  Uncertainty is introduced by conflicting macroeconomic signals.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXXX   | XX% | XXXXXX  | XX% | XXXXXX   | XX% |
| Reddit  | XX       | X%  | XX      | X%  | X        | X%  |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXXX   | XX% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Summit Therapeutics Inc. Common Stock

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +16%
6 Months: XX% +5%
1 Year: XX% +14%
1-Year High: XXX% on 2025-10-06
1-Year Low: XX% on 2025-03-23

Most Supportive Themes

  • Upcoming Phase X Data: (40%) The anticipation of upcoming Phase X data fuels investor excitement.
  • Bullish Sentiment and Recognition: (30%) Positive mentions and recognition of Summit Therapeutics as a potential long-term holding boost investor confidence.
  • Strategic Partnerships: (10%) Strategic collaborations, such as the ADC combo deal with Pfizer, are viewed positively by investors.

Most Critical Themes

  • Competition Intensification: (3%) Investors are concerned about increased competition in the PD-1/VEGF bispecific antibody market.
  • Conflicting Macroeconomic Signals: (2%) Uncertainty is introduced by conflicting macroeconomic signals.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXXX XX% XXXXXX XX% XXXXXX XX%
Reddit XX X% XX X% X X%
YouTube X X% X X% X X%
Total XXXXXX XX% XXXXXX XX% XXXXXX XX%
Summit Therapeutics Inc. Common Stock (SMMT) Sentiment
/topic/$smmt/sentiment